Tuesday, January 16, 2024 4:18:50 PM
To 1.00;((
Recent ELAB News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:01:35 PM
- Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity • GlobeNewswire Inc. • 05/02/2024 12:30:00 PM
- Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare • GlobeNewswire Inc. • 05/01/2024 08:00:00 PM
- Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments • GlobeNewswire Inc. • 05/01/2024 01:00:00 PM
- Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments • GlobeNewswire Inc. • 04/29/2024 01:45:37 PM
- ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results • GlobeNewswire Inc. • 03/29/2024 04:00:00 PM
- Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market • InvestorsHub NewsWire • 03/18/2024 12:51:03 PM
- ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office • GlobeNewswire Inc. • 01/24/2024 01:30:00 PM
- ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach • InvestorsHub NewsWire • 01/17/2024 02:07:02 PM
- ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach • GlobeNewswire Inc. • 01/17/2024 01:30:00 PM
- ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology • InvestorsHub NewsWire • 01/16/2024 03:05:05 PM
- ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences • GlobeNewswire Inc. • 01/02/2024 02:15:00 PM
- Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 12/11/2023 02:15:00 PM
- ELEVAI Labs, Inc. Expands International Distribution into Europe • GlobeNewswire Inc. • 12/07/2023 02:41:56 PM
- Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products • GlobeNewswire Inc. • 11/29/2023 02:00:00 PM
- ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering • PR Newswire (US) • 11/24/2023 06:38:00 PM
- Univest Securities, LLC Announces Closing of $6 Million Initial Public Offering of Common Stock for its Client ELEVAI Labs Inc. (Nasdaq: ELAB) • GlobeNewswire Inc. • 11/24/2023 05:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM